Statistics

Total Visits

Views
Phase II study of dovitinib in first line metastatic or (nonresectable primary) adrenocortical carcinoma (ACC): SOGUG study 2011-035

Select a period of time:

Number of views in the range

Views
Phase II study of dovitinib in first line metastatic or (nonresectable primary) adrenocortical carcinoma (ACC): SOGUG study 2011-033

Views

Views
November 20230
December 20230
January 20242
February 20240
March 20240
April 20240
May 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
 

Top cities views

Views
Boardman1